Select Publications
Book Chapters
, 2006, 'Diagnosis and Monitoring of PML-RARα-Positive Acute Promyelocytic Leukemia by Quantitative RT-PCR', in Myeloid Leukemia, Springer Nature, pp. 127 - 147, http://dx.doi.org/10.1385/1-59745-017-0:127
Journal articles
, 2026, 'Mediated Urgency: Exploring GBTQ+ Perceptions of Antibiotic-Resistant Sexually Transmitted Infections', Sociology of Health and Illness, 48, http://dx.doi.org/10.1111/1467-9566.70137
, 2025, 'A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study', BMC Infectious Diseases, 25, http://dx.doi.org/10.1186/s12879-025-12004-z
, 2025, 'Emerging Dilemmas in the Age of Resistance: The Case of Sexually Transmitted Infections', Qualitative Health Research, 35, pp. 1437 - 1449, http://dx.doi.org/10.1177/10497323241302668
, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859
, 2025, 'GBTQ+ safe sex entanglements: Finding the bacterial in the age of resistant STIs and prevention innovation', Social Science and Medicine, 379, pp. 118162 - 118162, http://dx.doi.org/10.1016/j.socscimed.2025.118162
, 2025, '“It's not just running the test”: Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia', International Journal of Drug Policy, 140, pp. 104800, http://dx.doi.org/10.1016/j.drugpo.2025.104800
, 2025, 'Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communities', Medical Journal of Australia, 222, pp. 172 - 178, http://dx.doi.org/10.5694/mja2.52589
, 2025, 'Treatment ‘cultures’, sexually transmitted infections and the rise of antimicrobial resistance', Sociology of Health and Illness, 47, http://dx.doi.org/10.1111/1467-9566.13832
, 2024, 'Pre-market health systems barriers and enablers to infectious diseases point-of-care diagnostics in Australia: qualitative interviews with key informants', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-10214-5
, 2024, 'Unnecessary antibiotic use in men who have sex with men (MSM) with anogenital symptoms attending a sexual health clinic: a retrospective analysis', Sexually Transmitted Infections, 100, pp. 435 - 441, http://dx.doi.org/10.1136/sextrans-2024-056120
, 2024, 'WHO global research priorities for antimicrobial resistance in human health', Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4
, 2024, 'Viability of Chlamydia trachomatis in Different Anatomical Sites-a Systematic Review and Meta-analysis', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciae401
, 2024, 'Syphilis point-of-care tests: an Australian perspective', Microbiology Australia, 45, pp. 127 - 131, http://dx.doi.org/10.1071/MA24036
, 2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101119
, 2024, 'External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles', Diagnostics, 14, http://dx.doi.org/10.3390/diagnostics14111106
, 2024, 'The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations', Microbiology Australia, 45, pp. 48 - 53, http://dx.doi.org/10.1071/MA24017
, 2024, 'Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26251
, 2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9
, 2024, 'Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care-Real world lessons from remote Australia', Expert Review of Molecular Diagnostics, 24, pp. 1125 - 1138, http://dx.doi.org/10.1080/14737159.2024.2403091
, 2024, 'We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?', Expert Review of Molecular Diagnostics, 24, pp. 177 - 191, http://dx.doi.org/10.1080/14737159.2023.2292645
, 2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet regional health. Western Pacific, 48
, 2023, 'National Surveillance of Home-Based HIV Testing Among Australian Gay and Bisexual Men, 2018–2020: Uptake After Commercial Availability of HIV Self-Tests', AIDS and Behavior, 27, pp. 4106 - 4113, http://dx.doi.org/10.1007/s10461-023-04124-x
, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', Ssm Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
, 2023, 'Reinfection incidence and risk among people treated for recent hepatitis C virus infection', AIDS, 37, pp. 1883 - 1890, http://dx.doi.org/10.1097/QAD.0000000000003651
, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
, 2023, 'Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar', Viruses, 15, pp. 521, http://dx.doi.org/10.3390/v15020521
, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
, 2022, 'Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review', Journal of Infectious Diseases, 226, pp. 1005 - 1021, http://dx.doi.org/10.1093/infdis/jiac049
, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
, 2022, 'Supply-side readiness to deliver HIV testing and treatment services in Indonesia: Going the last mile to eliminate mother-to-child transmission of HIV', Plos Global Public Health, 2, http://dx.doi.org/10.1371/journal.pgph.0000845
, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', Jhep Reports, 4, pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462
, 2022, 'Preferences for HIV testing services and HIV self-testing distribution among migrant gay, bisexual and other men who have sex with men in Australia', Frontiers in Medicine, 9, pp. 839479 - 839479, http://dx.doi.org/10.3389/fmed.2022.839479
, 2021, 'Sustaining success: a qualitative study of gay and bisexual men’s experiences and perceptions of HIV self-testing in a randomized controlled trial', BMC Public Health, 21, pp. 2048, http://dx.doi.org/10.1186/s12889-021-12011-0
, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
, 2021, 'Evaluation of hepatitis C virus core antigen assay in a resource-limited setting in Pakistan', Diagnostics, 11, http://dx.doi.org/10.3390/diagnostics11081354
, 2021, 'A decentralised point-of-care testing model to address inequities in the COVID-19 response', Lancet Infectious Diseases, 21, pp. e183 - e190, http://dx.doi.org/10.1016/S1473-3099(20)30859-8
, 2021, 'The costs of scaling up HIV and syphilis testing in low-and middle-income countries: A systematic review', Health Policy and Planning, 36, pp. 939 - 954, http://dx.doi.org/10.1093/heapol/czab030
, 2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253
, 2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, 223, pp. 818 - 826, http://dx.doi.org/10.1093/infdis/jiaa442
, 2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, http://dx.doi.org/10.1093/infdis/jiaa442
, 2021, 'The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial', The Lancet Regional Health - Western Pacific, 14, pp. 100214 - 100214, http://dx.doi.org/10.1016/j.lanwpc.2021.100214
, 2020, 'Novel hepatitic C virus (HCV) diagnosis and treatment delivery systems: Facilitating HCV elimination by thinking outside the clinic', Journal of Infectious Diseases, 222, pp. S758 - S772, http://dx.doi.org/10.1093/infdis/jiaa366
, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
, 2020, 'Modeling based response guided therapy in subjects with recent hepatitis C infection', Antiviral Research, 180, http://dx.doi.org/10.1016/j.antiviral.2020.104862
, 2020, 'Time to Detection of Hepatitis C Virus Infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis', Journal of Infectious Diseases, 221, pp. 2043 - 2049, http://dx.doi.org/10.1093/infdis/jiaa037
, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, 3, http://dx.doi.org/10.1002/hsr2.151
, 2020, 'Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance', Hepatology Communications, 4, pp. 904 - 915, http://dx.doi.org/10.1002/hep4.1496